Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?-Reference-Cited by-同舟云学术

Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

Published:2024-03-09 Issue:6 Volume:31 Page:3868-3869
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Shen Yi,Chen Longqi,Che Guowei

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15100-7.pdf

Reference5 articles.

1. Feng J, Wang L, Yang X, Chen Q, Cheng X. Pretreatment pan-immune-inflammation value (PIV) in predicting therapeutic response and clinical outcomes of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2024;31:272–83.

2. Baba Y, Nakagawa S, Toihata T, et al. Pan-immune-inflammation value and prognosis in patients with esophageal cancer. Ann Surg Open. 2022;3:e113.

3. Song K, Fei S, Li B, Tian J. Application of preoperative pan-immno-inflammatory values in clinicopathological features and prognosis evaluation of esophageal cancer. Mod Dig Interv. 2022;27:834–9.

4. Feng J, Wang L, Yang X, Chen Q, Cheng X. Clinical utility of preoperative pan-immune-inflammation value (PIV) for prognostication in patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2023;123:110805.

5. Qi WX, Wang X, Li C, et al. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: an analysis from a prospective cohort. Thorac Cancer. 2023;14:1556–66.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”;Annals of Surgical Oncology;2024-02-23